|
AMASS version 2.0
- Released on 16 May 2022
Description:
AMASS v2.0 is implemented from AMASSplus that was released on 25 Mar 2021. AMASS v2.0 additionally generates reports on notifiable bacterial diseases in Annex A and on data indicators (including proportion of contaminants and discordant AST results) in Annex B. AMASS version 2.0 also separately generates Supplementary data indictors report to support users to check and validate records at the local level. For any queries about AMASS, please contact AMASS team (amass@tropmedres.ac).
AMASSplus
- Released on 25 Mar 2021
Description:
The AMASSplus application is an extension of AMASS Version 1.1 that was released on 12 January 2021. AMASSplus has an additional report (page 38-40) on selected notifiable bacterial diseases. For implementation of AMASSplus at your hospitals in Thailand, please contact Preeyarach Klaytong (preeyarach@tropmedres.ac) and Viriya Hantrakun (viriya@tropmedres.ac).
AMASS version 1.1
- Released on 12 Jan 2021
Description:
This is a version with bugs fixed. AMASS 1.1 fixes a typo in the R codes of the AMASS 1.0 that caused inaccurate estimations of the proportion of non-susceptible isolates of E. coli and K. pneumoniae for ampicillin (page 9-10 and page 18-21 in the AMR surveillance report).
Version Beta 12102019
- Released on 12 Oct 2019
Description:
This is a beta version with new sections added, typos corrected and bug fixed from Version_Beta_26022019. In this version, there are 6 completed sections. The sections are [1] Data overview; [2] Isolated-based surveillance report without stratification by infection origin; [3] Isolated-based surveillance report with stratification by infection origin; [4] Sample-based surveillance report without stratification by infection origin; [5] Sample-based surveillance report with stratification by infection origin; and [6] Mortality in AMR and antimicrobial-susceptible infections.
Version Beta 26022019
- Released on 16 Feb 2019
Description:
This is the first released version of AMASS that contained 4 main sections. The sections are [1] General demographic data; [2] Isolated-based surveillance report without stratification by infection origin; [3] Isolated-based surveillance report with stratification by infection origin; and [5] Mortality in AMR and antimicrobial-susceptible infections. Please note that in this version, Section [4] on Sample-based surveillance report was under development (incomplete).
|